Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid in Alloplastic Breast Reconstruction
NCT04918589Phase 3Unknown
- Sponsor
- McMaster University
- Start
- Aug 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in postoperative hematoma (2 arms), sponsored by McMaster University. Primary endpoints: Incidence of Surgical Site Hematoma at 2 weeks and Incidence of Seroma at 2 weeks. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
postoperative hematoma
Beyond the preview
Go deeper on NCT04918589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04918589.